Thermo Fisher Scientific Share Price Berne S.E.
Equities
TFS
US8835561023
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
514.5 CHF | -0.35% | -0.35% | +19.58% |
10/05 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
10/05 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Sales 2024 * | 43.01B 38.79B 3,586B | Sales 2025 * | 46.08B 41.56B 3,843B | Capitalization | 227B 205B 18,933B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B 5.54B 513B | Net income 2025 * | 6.97B 6.29B 581B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 21.64B 2,001B | Net Debt 2025 * | 19.18B 17.3B 1,600B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.4
x | P/E ratio 2025 * |
32.1
x | Employees | - |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | -0.35% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
Director of Finance/CFO | 57 | 01/01/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01/01/01 |
C. Harris
BRD | Director/Board Member | 67 | 30/12/30 |
Ruby Chandy
BRD | Director/Board Member | 62 | 01/22/01 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.88% | 192B | |
+18.39% | 136B | |
+28.78% | 108B | |
+1.67% | 64.07B | |
+18.24% | 52.1B | |
+7.04% | 51.87B | |
+10.83% | 44.33B | |
+5.94% | 36.75B | |
+28.26% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TFS Stock